4 years ago

TrakCel Secures Investment for Cellular Therapy Orchestration Solution

  • TrakCel, a Cardiff-based supplier of cellular orchestration solutions, has received an undisclosed investment led by AmerisourceBergen and Labcorp

  • The funds will be used to further develop its cellular therapy orchestration solution and expand globally.

      • ProblemHealthcare

      "TrakCel aims to simplify and standardize the complex supply chain management for cell and gene therapies by providing real-time control over the entire therapeutic supply chain."

      Solution

      "TrakCel offers an integrated technology platform that manages the international autologous and allogeneic cell, gene, and immunotherapy supply chain, accelerating global scale-up and scale-out of cell and gene therapy products."

      Covered on